To Pull or Not to Pull:
Periapical Surgery vs. Implant Replacement
What alternative treatment options should be considered when a restorative and/or endodontic failure occurs?
Advancements in delivering periapical surgery have resulted in success rates that can be equivalent to implant replacement when certain guidelines are adhered to. Periapical surgery as an adjunct to endodontic treatment is a proven approach. With the introduction of new surgical techniques and a systematic method to the diagnosis and treatment of compromised teeth, the clinician should be able to more accurately determine the long-term prognosis for these treatment options.
This course will describe the indications and contraindications for performing or referring a patient for apical surgery. With a specific 7 step workup, including a correct history, radiographic and clinical evaluation, the decision to perform an apicoectomy will be weighed against further evaluation, a re- treatment option, or extraction and replacement with an implant (immediate or delayed). As a result, a decision is more accurately made as to whether an implant or a fixed bridge (fixed partial prosthesis), a removable prosthesis (fixed or transitional temporary prosthesis), or other options would be the final treatment plan discussed with the patient.
We will evaluate treatment options with an evidence-based approach when a tooth is ailing or failing. We will also discuss CBCT analysis for treatment planning as well as offering multiple unique treatment options for dental implant treatment planning that can be utilized for compromised and difficult cases.
2 CE | AGD 310 Oral & Maxillofacial Surgery
7:00 PM | Inn at Henderson's Wharf
with Daniel Pompa, DDS
Participants will learn and gain an understanding of:
The radiographic technique to use when evaluating a tooth for a fracture;
The 7 step work-up, consisting of procedures and tests that should be used when performing or referring a patient for an apicoectomy;
The principles of guided tissue regeneration, and know the indications and contraindications for its use;
How to recognize how the location of a sinus tract can be a key critical diagnostic indicator for the final prognosis; and
Identify the signs to differentiate between an Endo/Perio vs. Perio/Endo lesions and understand the difference as it relates to the final prognosis.
ABOUT OUR SPEAKER:
Dr. Daniel Pompa is an Oral and Maxillofacial Surgeon. He is a Fellow in both the American Association of Oral and Maxillofacial Surgeons and the International Congress of Oral Implantologists. He has been a guest speaker at numerous institutions, such as Columbia University College of Dental Medicine and New York University College of Dentistry, University of Maryland School of Dentistry, University of Pittsburgh School of Dental Medicine, University of Minnesota School of Dentistry, and at the University of Tennessee College of Dental Medicine.
Dr. Pompa is an author with six courses on-line and has published in journals such as: The Journal of the American Dental Association, Dentistry Today and the New York State Journal of the Academy of General Dentistry. He has been featured as a Seminar Series Speaker/Consultant for the American Dental Association. Dr. Pompa is now a Colgate Speaker and has the course “Medical Emergencies in the Dental Practice” on the Colgate Website. In Dentistry Today, Dr. Pompa has been cited as a “Leader in Continuing Education for 2018, 2019
and 2020”. He has presented over 600 lectures both nationally and internationally.
Dr. Pompa practiced for over 30 years in New York and now lectures full-time. He has organized several Charity Golf Tournaments to raise money for our Veterans at the Northport VA Hospital and is now the host of the "New York Classic Film Club" which is in its fifth year and meets at the Port Washington Public Library on Long Is- land, New York. He is also an inventor, having been issued a U.S. Patent for his contribution in developing a protocol for CT Guided Surgery in Dental Implantology. His patent (U.S. Patent #5,320,529) is cited today by over 250 patents.